Point72 Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-395,750
| Closed | -$28M | – | 1350 |
|
2025
Q1 | $28M | Buy |
395,750
+129,314
| +49% | +$9.14M | 0.06% | 315 |
|
2024
Q4 | $17.5M | Buy |
266,436
+68,718
| +35% | +$4.52M | 0.04% | 422 |
|
2024
Q3 | $13.9M | Buy |
+197,718
| New | +$13.9M | 0.04% | 435 |
|
2024
Q2 | – | Sell |
-1,345,720
| Closed | -$118M | – | 1236 |
|
2024
Q1 | $118M | Buy |
1,345,720
+890,420
| +196% | +$77.8M | 0.28% | 65 |
|
2023
Q4 | $43.9M | Buy |
+455,300
| New | +$43.9M | 0.11% | 235 |
|
2023
Q1 | – | Sell |
-716,700
| Closed | -$74.2M | – | 1700 |
|
2022
Q4 | $74.2M | Buy |
716,700
+121,300
| +20% | +$12.6M | 0.25% | 98 |
|
2022
Q3 | $50.5M | Buy |
595,400
+447,529
| +303% | +$37.9M | 0.2% | 121 |
|
2022
Q2 | $12.3M | Sell |
147,871
-218,965
| -60% | -$18.1M | 0.05% | 414 |
|
2022
Q1 | $28.3M | Sell |
366,836
-454,960
| -55% | -$35.1M | 0.11% | 218 |
|
2021
Q4 | $72.6M | Buy |
821,796
+30,007
| +4% | +$2.65M | 0.29% | 70 |
|
2021
Q3 | $61.2M | Buy |
791,789
+425,289
| +116% | +$32.9M | 0.27% | 70 |
|
2021
Q2 | $30.6M | Buy |
366,500
+110,000
| +43% | +$9.18M | 0.14% | 181 |
|
2021
Q1 | $19.4M | Sell |
256,500
-124,600
| -33% | -$9.41M | 0.09% | 263 |
|
2020
Q4 | $33.4M | Sell |
381,100
-562,593
| -60% | -$49.3M | 0.16% | 164 |
|
2020
Q3 | $71.8M | Buy |
+943,693
| New | +$71.8M | 0.37% | 51 |
|
2020
Q1 | – | Sell |
-260,683
| Closed | -$22M | – | 753 |
|
2019
Q4 | $22M | Buy |
260,683
+196,010
| +303% | +$16.6M | 0.12% | 232 |
|
2019
Q3 | $4.36M | Sell |
64,673
-186,973
| -74% | -$12.6M | 0.03% | 445 |
|
2019
Q2 | $21.6M | Buy |
+251,646
| New | +$21.6M | 0.11% | 197 |
|
2018
Q3 | – | Sell |
-53,703
| Closed | -$5.06M | – | 854 |
|
2018
Q2 | $5.06M | Sell |
53,703
-198,397
| -79% | -$18.7M | 0.02% | 482 |
|
2018
Q1 | $20.4M | Sell |
252,100
-245,249
| -49% | -$19.9M | 0.09% | 241 |
|
2017
Q4 | $44.3M | Sell |
497,349
-272,193
| -35% | -$24.3M | 0.19% | 120 |
|
2017
Q3 | $71.6M | Buy |
+769,542
| New | +$71.6M | 0.32% | 60 |
|
2017
Q2 | – | Sell |
-364,800
| Closed | -$32M | – | 727 |
|
2017
Q1 | $32M | Sell |
364,800
-161,800
| -31% | -$14.2M | 0.18% | 139 |
|
2016
Q4 | $43.6M | Buy |
526,600
+372,900
| +243% | +$30.9M | 0.31% | 88 |
|
2016
Q3 | $14.2M | Buy |
+153,700
| New | +$14.2M | 0.1% | 219 |
|
2015
Q1 | – | Sell |
-74,600
| Closed | -$6.74M | – | 641 |
|
2014
Q4 | $6.74M | Sell |
74,600
-601,000
| -89% | -$54.3M | 0.05% | 364 |
|
2014
Q3 | $48.8M | Buy |
675,600
+585,500
| +650% | +$42.2M | 0.37% | 62 |
|
2014
Q2 | $5.61M | Buy |
+90,100
| New | +$5.61M | 0.04% | 407 |
|